Dr. Arkaitz Carracedo received his PhD in Biochemistry and Molecular Biology from the Complutense University of Madrid in 2006. After 4 years of postdoctoral work at Memorial Sloan-Kettering Cancer Center Hospital and Beth Israel Deaconess Medical Center, Harvard Medical School (USA), he established his research line at CIC bioGUNE at the end of 2010 with the primary objective of studying the unique biological characteristics of cancer cells in vitro and in vivo, with emphasis on cell metabolism alterations. Since 2011 he is Ikerbasque Research Professor and, since 2012, Associate Professor at the University of the Basque Country. He has influenced the field of cancer metabolism with 108 scientific publications and reviews and the organization of internationally recognized congresses. This, in turn, has granted him a variety of awards and recognitions, as well as the funding of his research by the most important agents in the national and international scene, from foundations such as the AECC to the European Research Council with 3 ERC projects.